Stay updated on IMMU-132 Clinical Trial in Epithelial Cancer
Sign up to get notified when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.

Latest updates to the IMMU-132 Clinical Trial in Epithelial Cancer page
- Check2 days agoChange DetectedNew navigation/help sections were added to assist users (How to Read a Study Record, Common Questions, How to Join a Study) and the page now explicitly states that enrollment has ceased for this study. A revision badge (Revision: v3.6.0) was added, replacing the previous version label (v3.5.5), and a minor header naming adjustment occurred for the 'Intervention/Treatment' section.SummaryDifference0.3%

- Check9 days agoChange DetectedThe page's revision label updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a newer version of the page. This is a small metadata update rather than a substantive change to study details.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing Revision: v3.5.3, indicating a new build/version of the page.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, reflecting a site software release rather than a change to the underlying study details.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed from the revision log.SummaryDifference0.0%

- Check73 days agoChange DetectedThe term 'Small cell lung carcinoma' was added to the list of tumor types. This aligns terminology but does not alter any study details or requirements.SummaryDifference0.0%

Stay in the know with updates to IMMU-132 Clinical Trial in Epithelial Cancer
Enter your email address, and we'll notify you when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.